Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05243810Not ApplicableCompleted

EPC Silver Wound Gel (EPC-123) Feasibility Study in the Management of Mildly Infected Diabetic Foot Ulcers

Role: lead

NCT02990832Not ApplicableWithdrawn

Diabetes Foot Care Clinical Pathway Project - Exciton Technologies Inc

Role: collaborator

NCT02662101Not ApplicableCompleted

Impact of Oxidized Silver Wound Dressings on Wound Bacteria

Role: lead

NCT00968994Not ApplicableUnknown

Trial of exSALT SD7™ Compared to Xeroform® Petrolatum Dressing for the Management of Partial Thickness Donor Sites

Role: lead

All 4 trials loaded